Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study
NCT05771298 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-03-16
Summary
To compare the efficacy and safety of 532 nm KTP and 585 nm PDL for treating rosacea.
Conditions
- Rosacea
Interventions
- DEVICE
-
532nm KTP
one to three treatment sessions
- DEVICE
-
585nm PDL
one to three treatment sessions
Sponsors & Collaborators
-
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Principal Investigators
-
L Nguyen, MD · Universitätsklinikum Hamburg-Eppendorf
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2023-05-01
- Completion
- 2023-06-01
Countries
- Germany
Study Locations
More Related Trials
-
Comparative Study of Low-Energy 1064nm Laser and DPL in Rosacea Treatment
NCT06915636 ·Status: COMPLETED ·Phase: NA
-
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser
NCT03472859 ·Status: COMPLETED ·Phase: NA
-
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
NCT01529996 ·Status: COMPLETED ·Phase: NA
-
Study of TP-04 in Participants With Papulopustular Rosacea
NCT05838170 ·Status: COMPLETED ·Phase: PHASE2
-
Brimonidine in Rosacea
NCT05401422 ·Status: UNKNOWN ·Phase: NA
-
Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa
NCT03203122 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients
NCT02052999 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea
NCT03708263 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
NCT02131636 ·Status: COMPLETED ·Phase: PHASE3
-
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea
NCT02144181 ·Status: COMPLETED ·Phase: NA
-
Combination Gel and Vascular ND in Mild to Moderate Rosacea
NCT01631656 ·Status: COMPLETED ·Phase: NA
-
Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea
NCT03053700 ·Status: WITHDRAWN ·Phase: PHASE4
-
Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma
NCT05036200 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
NCT01449591 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
NCT01257919 ·Status: COMPLETED ·Phase: PHASE1
-
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
NCT06745999 ·Status: RECRUITING ·Phase: PHASE4
-
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
NCT04153188 ·Status: COMPLETED ·Phase: PHASE4
-
Patient-Reported Outcome Of Facial Erythema (PROOF)
NCT01885000 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of CD07805/47 Gel in Rosacea Flushing
NCT02300129 ·Status: COMPLETED ·Phase: PHASE2
-
Photodynamic Therapy for Papulopustular Rosacea
NCT02075671 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy
NCT04156815 ·Status: COMPLETED ·Phase: NA
-
A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
NCT03448939 ·Status: COMPLETED ·Phase: PHASE3
-
AGN-199201 for the Treatment of Erythema With Rosacea
NCT01735201 ·Status: COMPLETED ·Phase: PHASE2
-
Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris
NCT00814918 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
NCT01579084 ·Status: COMPLETED ·Phase: PHASE1